Targeting metabolic dysregulation for fibrosis therapy
Fibrosis is the abnormal deposition of extracellular matrix, which can lead to organ
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …
Therapy for fibrotic diseases: nearing the starting line
SL Friedman, D Sheppard, JS Duffield… - Science translational …, 2013 - science.org
Fibrosis, or the accumulation of extracellular matrix molecules that make up scar tissue, is a
common feature of chronic tissue injury. Pulmonary fibrosis, renal fibrosis, and hepatic …
common feature of chronic tissue injury. Pulmonary fibrosis, renal fibrosis, and hepatic …
Targeting fibrosis: Mechanisms and clinical trials
M Zhao, L Wang, M Wang, S Zhou, Y Lu… - Signal transduction and …, 2022 - nature.com
Fibrosis is characterized by the excessive extracellular matrix deposition due to
dysregulated wound and connective tissue repair response. Multiple organs can develop …
dysregulated wound and connective tissue repair response. Multiple organs can develop …
[HTML][HTML] Drugs and targets in fibrosis
Fibrosis contributes to the development of many diseases and many target molecules are
involved in fibrosis. Currently, the majority of fibrosis treatment strategies are limited to …
involved in fibrosis. Currently, the majority of fibrosis treatment strategies are limited to …
Therapeutic targets in liver fibrosis
JA Fallowfield - American Journal of Physiology …, 2011 - journals.physiology.org
Detailed analysis of the cellular and molecular mechanisms that mediate liver fibrosis has
provided a framework for therapeutic approaches to prevent, slow down, or even reverse …
provided a framework for therapeutic approaches to prevent, slow down, or even reverse …
Fibrosis: from mechanisms to medicines
NC Henderson, F Rieder, TA Wynn - Nature, 2020 - nature.com
Fibrosis can affect any organ and is responsible for up to 45% of all deaths in the
industrialized world. It has long been thought to be relentlessly progressive and irreversible …
industrialized world. It has long been thought to be relentlessly progressive and irreversible …
Emerging therapeutic targets for the treatment of hepatic fibrosis
P Fagone, K Mangano, A Pesce, TR Portale… - Drug Discovery …, 2016 - Elsevier
Highlights•Liver fibrosis is an important health problem associated to morbility and
mortality.•Extensive data have provided knowledge of the major key cellular and molecular …
mortality.•Extensive data have provided knowledge of the major key cellular and molecular …
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Liver fibrosis and in particular cirrhosis are the major causes of morbidity and mortality of
patients with chronic liver disease. Their prevention or reversal have become major …
patients with chronic liver disease. Their prevention or reversal have become major …
Evolving therapies for liver fibrosis
D Schuppan, YO Kim - The Journal of clinical investigation, 2013 - Am Soc Clin Investig
Fibrosis is an intrinsic response to chronic injury, maintaining organ integrity when extensive
necrosis or apoptosis occurs. With protracted damage, fibrosis can progress toward …
necrosis or apoptosis occurs. With protracted damage, fibrosis can progress toward …
Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis
J Lambrecht, LA van Grunsven… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Chronic liver disease is due to various causes of persistent liver damage and
will eventually lead to the development of liver fibrosis. If no treatment is initiated, this …
will eventually lead to the development of liver fibrosis. If no treatment is initiated, this …